Pancreatic cancer cell and gene biotherapies; past, present and future
Pancreatic cancer cell and gene biotherapies; past, present and future Pancreatic cancer Biotherapy gene therapy Lorraine Quillien Team Impact – Therapeutic innovation in pancreatic cancer – Team Leader Pierre Cordelier Solid cancers remain a major health...
The Roland Garigou Foundation for Culture & Health awards several prizes and grants to the CRCT in 2022
The Roland Garigou Foundation for Culture & Health awards several prizes and grants to the CRCT in 2022 The Fonroga Foundation supports initiatives and achievements in the fields of culture and health in the Toulouse region. On 15 November 2022 it awarded several...
NeoVirTech SAS opens a new laboratory at the Cancerology Research Center of Toulouse (CRCT)
NeoVirTech SAS opens a new laboratory at the Cancerology Research Center of Toulouse (CRCT) Pierre Cordelier équipe ImPact : Therapeutic innovation in pancreatic cancer and two members of Neovirtech, Franck Gallardo (CEO) and Elie marcheteau NeoVirTech SAS opens a new...
TLR7 agonists have dual effect on pancreatic tumors that jeopardize their use in clinics
TLR7 agonists have dual effect on pancreatic tumors that jeopardize their use in clinics Pancreatic cancer toll like receptors tumor microenvironment Pierre Cordelier équipe ImPact : Innovation thérapeutique dans le cancer du pancréas Toll like receptors (TLR) are key...
